Arturo Md Molina Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

Arturo Md Molina is Chief Medical Officer of Protagonist Therapeutics, Inc. Currently has a direct ownership of 48,350 shares of PTGX, which is worth approximately $2.03 Million. The most recent transaction as insider was on Jan 16, 2024, when has been sold 427 shares (Common Stock) at a price of $24.63 per share, resulting in proceeds of $10,517. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K
0% 3M change
98.36% 12M change
Total Value Held $2.03 Million

ARTURO MD MOLINA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2024
SELL
Payment of exercise price or tax liability
$10,517 $24.63 p/Share
427 Reduced 0.88%
48,350 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
26,250 Added 34.99%
48,777 Common Stock
Nov 15 2023
SELL
Open market or private sale
$30,011 $16.24 p/Share
1,848 Reduced 7.58%
22,527 Common Stock
Jan 16 2023
BUY
Grant, award, or other acquisition
-
3,125 Added 11.36%
24,375 Common Stock
Nov 15 2022
BUY
Grant, award, or other acquisition
-
21,250 Added 50.0%
21,250 Common Stock

Also insider at

STRO
SUTRO BIOPHARMA, INC. Healthcare
Chief Medical Officer
FMTX
Forma Therapeutics Holdings, Inc. Healthcare
Director
AMM

Arturo Md Molina

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX